Publication: Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
No Thumbnail Available
Identifiers
Date
2019-06-04
Authors
Garcia-Leon, Juan Antonio
Vitorica, Javier
Gutierrez, Antonia
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Most neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust in vitro disease modeling and drug screening platforms for most common neurodegenerative conditions.
Description
MeSH Terms
Animals
CRISPR-Cas Systems
Drug Evaluation, Preclinical
Gene Editing
Humans
Neurodegenerative Diseases
Neurogenesis
Neurons
Pluripotent Stem Cells
CRISPR-Cas Systems
Drug Evaluation, Preclinical
Gene Editing
Humans
Neurodegenerative Diseases
Neurogenesis
Neurons
Pluripotent Stem Cells
DeCS Terms
CIE Terms
Keywords
Alzheimer’s disease, CRISPR-Cas9, Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, disease modeling, drug screening, hiPSCs, human-induced pluripotent stem cells, multiple sclerosis, neurodegenerative disease